BACKGROUND INFORMATION ON THE PROCEDURE 
1. 
Submission of the dossier 
The  applicant  Amgen  Europe  B.V    submitted  on  10  October  2003  an  application  for  Marketing 
Authorisation to the European Agency for the Evaluation of Medicinal Products (EMEA) for Mimpara, 
through  the  centralised  procedure.  After  agreement  by  the  CHMP  on  1  May  2003, this medicinal 
product has been referred to Part B of the Annex to Council Regulation No (EEC) 2309/93 of 22 July 
1993 as amended. 
The Rapporteur and Co-Rapporteur appointed by the CHMP were: 
Rapporteur:  Dr. Per Nilsson 
Co-Rapporteur: 
Dr. Josef Suko  
Scientific Advice: 
The applicant did not seek scientific advice at the CHMP. 
Licensing status: 
The product was not licensed in any country at the time of submission of the application. 
2. 
Steps taken for the assessment of the product 
• 
• 
• 
• 
• 
• 
• 
The procedure started on 27 October 2003. 
The Rapporteur's first Assessment Report was circulated to all CHMP members on 9 January 
2004 . The Co-Rapporteur's first Assessment Report was circulated to all CHMP members on 6 
January 2004. 
During  the  meeting  on  24-26  February  2004,  the  CHMP  agreed  on  the  consolidated  List  of 
Questions to be sent to the applicant. The final consolidated List of Questions was sent to the 
applicant on  26 February 2004. 
The applicant submitted the responses to the CHMP consolidated List of Questions on 14 May 
2004. 
The Rapporteurs circulated the Joint Assessment Report on the applicant’s responses to the List 
of Questions to all CHMP members on  24 June 2004. 
During the meeting on   27-29 July 2004, the CHMP, in the light of the overall data submitted and 
the scientific discussion within the Committee, issued a positive opinion for granting a Marketing 
Authorisation  to  Mimpara  on  29  July  2004. The applicant provided the letter of undertaking on 
the follow-up measures to be fulfilled post-authorisation on 28 July 2004. 
The  CHMP  opinions  were  forwarded,  in  all  official  languages  of  the  European  Union,  to  the 
European Commission, which adopted the corresponding Decisions on 22 October 2004. 
1/1 
ª EMEA 2004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
